查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1952647

多關節上肢復健機器人市場：按產品、技術、最終用戶和應用分類－全球預測（2026-2032）

Multi-joint Upper Limb Rehabilitation Robot Market by Product, Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，多關節上肢復健機器人市場價值將達到 3.6547 億美元，到 2026 年將成長至 4.1638 億美元，到 2032 年將達到 8.7247 億美元，複合年成長率為 13.23%。

關鍵市場統計數據
基準年 2025 3.6547億美元
預計年份：2026年 4.1638億美元
預測年份 2032 8.7247億美元
複合年成長率 (%) 13.23%

本文簡要概述了影響關節式上肢復健機器人設計選擇和應用路徑的臨床、技術和操作環境。

本執行摘要探討了關節式上肢復健機器人的發展現狀，並概述了設計者、臨床醫生和投資者所處的技術和臨床背景。復健機器人技術已超越概念驗證階段，目前正被應用於醫院、門診復健中心，並擴大應用於家庭環境中。驅動機制、感測技術、人機介面和控制演算法的進步，使得相關設備能夠支援複雜的多平面上肢運動，並適應患者特定的運動模式。

這是一個重要的技術、臨床和交付模式轉折點，它將重新定義復健機器人領域的設備設計、治療範式和系統互通性。

上肢復健機器人領域正經歷著由多種因素共同推動的變革。首先，感測器小型化和輕量化致動器的進步催生了新一代穿戴式和可攜式系統，拓展了治療環境。嵌入式運算和邊緣人工智慧的進步使得自適應輔助和即時效能回饋無需依賴持續的雲端連接即可實現，從而提高了神經復健干預的可靠性並降低了延遲。

2025年前關稅變化對復健機器人製造商籌資策略、到岸成本和區域生產決策的影響

影響國際貿易和關稅的政策變化正對醫療設備製造商的採購、定價和分銷策略產生重大影響。近期實施的關稅調整（有效期至2025年）凸顯了了解零件、子組件和成品器械累積成本成長的重要性。這些措施促使製造商重新評估供應鏈，包括供應商多元化、關鍵生產過程回流以及產品架構的重新設計，以減少對關稅敏感型零件的依賴。

詳細的細分分析將產品形態、技術方案、最終用戶環境以及應用左右差異與商業化和設計優先順序連結起來。

我們的細分分析揭示了產品、技術、終端用戶和應用等各個維度上微妙的需求促進因素。按產品分類，我們將設備分為固定式和穿戴式式，並著重強調了二者不同的設計重點：固定式平台強調靈活支撐和臨床數據採集，而穿戴式式系統則優先考慮便攜性、易穿戴性和融入日常生活。按技術分類，我們分析了末端執行器和外骨骼市場，重點闡述了簡化控制的特定任務末端執行器解決方案與提供更自然關節輔助和本體感覺反饋的外骨骼架構之間的權衡取捨。

醫療保健系統、報銷環境以及重點地區的採用趨勢將如何影響產品策略和市場准入

區域趨勢正在塑造需求成長的地點、產品的採用方式以及供應商的差異化優勢。在美洲，醫療系統採用公私混合採購慣例，並且對能夠展現明確臨床療效並可整合到跨專業診療路徑中的醫療器材表現出濃厚的興趣。更嚴格的報銷審查和支付方對證據的要求，促使人們更加關注可證實的功能改善和成本效益指標，這正在影響採購週期和培訓投入。

從競爭定位的觀點，整合臨床證據、服務模式、軟體生態系統和製造韌性，以確定市場領導地位。

多關節上肢復健機器人領域的競爭格局呈現出多元化的特點，既有成熟的醫療設備製造商，也有專注於機器人Start-Ups，還有以軟體主導的新興參與企業。成熟的醫療設備製造商利用其臨床關係和分銷網路，拓展可整合到現有醫院工作流程中的解決方案；而Start-Ups強調快速的研發週期、創新的控制策略和差異化的用戶體驗。醫療設備製造商與數位醫療公司之間的策略聯盟日益普遍，這反映出將硬體可靠性與軟體主導的個人化遠端監測相結合的需求。

切實可行的策略挑戰，幫助企業提升臨床可靠性、供應鏈韌性、軟體整合以及針對特定市場的商業化策略。

產業領導者應推動一系列協作行動，在臨床、商業和營運層面創造價值。首先，應優先進行臨床檢驗研究，以證明在實際治療路徑下功能性改善，並設計證據產生方案，以滿足醫療負責人者和報銷相關人員的需求。來自臨床實施點和居家試點計畫的補充性真實世界數據（RWE）以及隨機對照試驗將用於建立全面的結果評估。

我們採用嚴格的混合方法，結合直接的臨床醫生對話、觀察歸納、文獻綜合和迭代專家檢驗，以支持我們的實踐發現。

本研究採用質性和量性結合的調查方法，以確保研究結果的可靠性和可重複性。主要研究包括對臨床醫生、採購專業人員、復健治療師和設備開發人員進行結構化訪談，以收集有關設備可用性、臨床需求和採購限制的第一手資訊。此外，還開展了在臨床和家庭環境中對設備實施情況的觀察性研究，以評估使用者流程、設定難度和維護注意事項。

對臨床證據、產品工程、供應鏈策略和區域市場推廣策略如何協同運作，以確定成功實施和對患者的影響進行綜合分析。

總而言之，關節式上肢復健機器人領域正處於一個轉折點，技術成熟度、不斷變化的醫療服務模式以及政策趨勢的交匯，為行業相關人員創造了加速發展的機會和責任。儘管設備的功能日益強大，並能更好地適應不同的醫療環境，但成功的商業化將取決於臨床證據、服務模式和區域市場需求之間的清晰契合。到2025年，供應鍊和關稅壓力凸顯了製造柔軟性和區域策略的必要性，這些策略旨在縮短產品上市時間，提高服務應對力，同時保持利潤率。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 多關節上肢復健機器人市場（依產品分類）

  • 固定式
  • 穿戴式裝置

9. 依技術分類的多關節上肢復健機器人市場

  • 末端執行器
  • 外骨骼

第10章 多關節上肢復健機器人市場（依最終用戶分類）

  • 居家照護
  • 醫院
  • 復健中心

第11章 多關節上肢復健機器人市場（按應用領域分類）

  • 雙方
  • 一邊
    • 左邊
    • 右側

第12章 各地區多關節上肢復健機器人市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 多關節上肢復健機器人市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國多關節上肢復健機器人市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 美國多關節上肢復健機器人市場

第16章 中國多關節上肢復健機器人市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Bionik Laboratories Corp.
  • Cyberdyne, Inc.
  • Ekso Bionics Holdings, Inc.
  • Focal Meditech BV
  • Fourier Intelligence Co., Ltd.
  • Hocoma AG
  • Honda Motor Co., Ltd.
  • Kinova Inc.
  • Marsi Bionics
  • Myomo, Inc.
  • Neofect Co., Ltd.
  • Ottobock SE & Co. KGaA
  • Parker-Hannifin Corporation
  • Reha Technology AG
  • ReWalk Robotics Ltd.
  • Steeper Group Ltd.
  • Tyromotion GmbH
  • UBTECH Robotics Corp.
  • Wandercraft SAS
  • Yaskawa Electric Corporation
Product Code: MRR-7A380DA7C554

The Multi-joint Upper Limb Rehabilitation Robot Market was valued at USD 365.47 million in 2025 and is projected to grow to USD 416.38 million in 2026, with a CAGR of 13.23%, reaching USD 872.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 365.47 million
Estimated Year [2026] USD 416.38 million
Forecast Year [2032] USD 872.47 million
CAGR (%) 13.23%

A concise orientation to the clinical, technological, and operational context shaping design choices and adoption pathways for multi-joint upper limb rehabilitation robotics

This executive summary introduces the evolving landscape of multi-joint upper limb rehabilitation robots, framing the technological and clinical context in which designers, clinicians, and investors operate. Rehabilitation robotics has moved beyond proof-of-concept demonstrations to enter deployment phases across hospitals, outpatient rehabilitation centers, and increasingly into the home setting. Improvements in actuation, sensing, human-machine interfaces, and control algorithms have converged to create devices that can support complex, multi-planar upper limb movements while adapting to patient-specific motor profiles.

Clinical evidence has matured, showing improvements in motor function when robotic therapy is combined with task-specific training and high-repetition practice. At the same time, manufacturers are responding to rising demand for devices that are compact, more affordable to operate, and easier for non-specialist caregivers to use. This introduction outlines the key drivers-technological, clinical, and economic-that are reshaping product design and adoption pathways. It also underscores the regulatory and reimbursement environments that influence device commercialization, and sets the stage for subsequent sections which examine market structure, trade policy impacts, regional dynamics, and actionable recommendations for scaling impact.

Major technological, clinical, and delivery-model inflection points that are redefining device design, therapy paradigms, and system interoperability in rehabilitation robotics

The landscape for upper limb rehabilitation robotics is undergoing transformative shifts driven by multiple converging forces. First, miniaturization of sensors and improved lightweight actuators have enabled a new generation of wearable and portable systems that expand the settings in which therapy can take place. Advances in embedded computing and edge AI permit adaptive assistance and real-time performance feedback without reliance on continuous cloud connectivity, increasing reliability and lowering latency for neurorehabilitation interventions.

Second, the therapy paradigm is shifting from therapist-directed, in-clinic sessions toward hybrid models that combine clinic-based intensive training with tele-rehabilitation and supervised home programs. This hybrid approach leverages remote monitoring, progress dashboards, and gamified therapy modules to maintain intensity and adherence outside the clinic. Third, software-driven personalization-rooted in data analytics, motor learning theory, and reinforcement learning-enables systems to adapt challenge levels and assistance profiles dynamically, maximizing neuroplastic gains while reducing risk of over-assistance.

Finally, manufacturing and supply chain innovations, including modular architectures and standardized interfaces, are fostering interoperability and lowering barriers to integration with electronic health records and hospital workflows. Taken together, these shifts create opportunities for new entrants and incumbent firms to redefine value propositions, emphasizing longitudinal outcomes, reduced clinician burden, and measurable cost-efficiencies across care pathways.

How tariff changes through 2025 have reshaped sourcing strategies, landed costs, and regional production decisions for rehabilitation robot manufacturers

Policy shifts affecting international trade and tariffs have materially influenced the sourcing, pricing, and distribution strategies of medical device manufacturers. Recent tariff changes implemented up to 2025 have increased the importance of understanding cumulative cost inflations across components, subassemblies, and finished devices. These measures have catalyzed supply chain re-evaluations, prompting manufacturers to diversify suppliers, onshore critical production steps, and redesign product architectures to reduce dependency on tariff-exposed components.

The cumulative impact of tariff adjustments is manifest in higher landed costs for imported components, which, combined with transportation and regulatory compliance costs, has pressured margins for makers of complex rehabilitation systems. In response, organizations are investing in regional manufacturing hubs, qualifying alternate suppliers in low-tariff jurisdictions, and redesigning bill-of-materials to prioritize locally sourced or tariff-resistant components. Procurement teams are negotiating longer-term contracts and greater price transparency with suppliers to smooth cost volatility.

Moreover, tariff-driven localization has implications for clinical adoption timelines. Devices manufactured closer to end markets tend to benefit from faster certification cycles, more responsive after-sales service, and improved supply continuity-factors that can accelerate hospital procurement decisions. While tariffs add near-term cost complexity, they also incentivize strategic investments in resilient supply chains and manufacturing flexibility that can yield long-term competitive advantage.

Detailed segmentation insights linking product form factor, technological approach, end-user setting, and application laterality to commercialization and design priorities

Segmentation analysis reveals nuanced demand drivers across product, technology, end user, and application dimensions. Based on Product, the market is studied across Stationary and Wearable, highlighting divergent design priorities where stationary platforms emphasize multi-degree-of-freedom support and clinical data capture while wearable systems prioritize portability, ease of donning, and integration into daily routines. Based on Technology, the market is studied across End Effector and Exoskeleton, underscoring the trade-offs between task-specific end-effector solutions that can simplify control and exoskeleton architectures that provide more natural joint-level assistance and proprioceptive feedback.

Based on End User, the market is studied across Home Care, Hospitals, and Rehabilitation Centers, illustrating how procurement cycles, reimbursement frameworks, and clinical workflows vary across settings and shape product feature prioritization. For instance, hospitals and rehabilitation centers typically demand robust data integration, serviceability, and multi-patient scalability, while home care buyers focus on usability, remote monitoring, and cost-effectiveness. Based on Application, the market is studied across Bilateral and Unilateral, with Unilateral further studied across Left and Right, emphasizing how laterality and bilateral coordination tasks influence device kinematics, adaptive algorithms, and therapy protocols.

Taken together, segmentation informs product roadmaps, pricing strategies, and commercialization plans. Developers should align engineering trade-offs with the primary use case and purchaser profile, ensuring that clinical validation pathways correspond to the intended deployment environment. Strategic segmentation also helps prioritize service models, data analytics offerings, and training resources to match the differentiated needs of institutional and consumer-facing channels.

How regional healthcare systems, reimbursement landscapes, and adoption behaviors across major global regions are shaping product strategies and market entry

Regional dynamics are shaping where demand grows, how products are adopted, and which capabilities become differentiators for suppliers. In the Americas, healthcare systems exhibit a mixture of public and private procurement practices with strong interest in devices that demonstrate clear clinical outcomes and that integrate into multidisciplinary care pathways. Reimbursement scrutiny and payer evidence requirements drive a preference for demonstrable functional gains and cost-per-outcome metrics, which influence purchasing timelines and training investments.

In Europe, Middle East & Africa, diverse regulatory regimes and fragmented procurement landscapes create opportunities for regional distributors and localized clinical partnerships. Adoption in this region often correlates with national rehabilitation priorities and the availability of community-based therapy programs, and success frequently depends on tailored service models and training for local clinician groups. In the Asia-Pacific region, rapid digital adoption, an expanding middle-class, and growing investment in home-based care are accelerating interest in both wearable and stationary solutions. Manufacturers that adapt pricing, service networks, and language-localized software stand to capture early growth across a broad spectrum of urban and emerging markets.

Across regions, the common imperative is to align go-to-market strategies with local reimbursement realities, clinician workflows, and patient expectations. Localized clinical evidence generation and strong distribution partnerships remain decisive factors in converting interest into sustained adoption.

An integrated look at competitive positioning combining clinical evidence, service models, software ecosystems, and manufacturing resilience that determines market leadership

Competitive dynamics within the multi-joint upper limb rehabilitation robotics sector are characterized by a mix of established medtech firms, specialized robotics startups, and software-first entrants. Incumbent medical device manufacturers leverage clinical relationships and distribution networks to scale solutions that integrate with existing hospital workflows, while startups emphasize nimble development cycles, innovative control strategies, and differentiated user experiences. Strategic alliances between device makers and digital health companies are increasingly common, reflecting the need to combine hardware reliability with software-driven personalization and remote monitoring.

Investment activity is concentrated on companies that can demonstrate replicable clinical outcomes, scalable manufacturing, and low total cost of ownership for providers. Service and support capabilities are a competitive differentiator, as long-term therapy success hinges on device uptime, training, and data analytics that inform therapy adjustments. Suppliers that offer outcome-tracking dashboards and compliance reporting enhance the value proposition for payers and institutional purchasers. Additionally, partnerships with rehabilitation clinics and academic centers for clinical validation programs remain central to building credibility and informing product iteration.

Given these dynamics, competitive positioning will continue to favor players who can marry rigorous clinical evidence with scalable service models, agile software ecosystems, and resilient supply chains.

Actionable strategic imperatives for companies to strengthen clinical credibility, supply chain resilience, software integration, and market-specific commercialization approaches

Industry leaders should pursue a set of coordinated actions to capture value across clinical, commercial, and operational dimensions. First, prioritize clinical validation studies that demonstrate functional improvements under realistic care pathways, and design evidence generation to satisfy both institutional purchasers and reimbursement stakeholders. Complement randomized or controlled trials with real-world evidence collected from clinical deployments and home-based pilots to build a comprehensive outcomes narrative.

Second, invest in modular design and supply chain flexibility to mitigate tariff and component risks while enabling rapid product customization for diverse end users. This includes qualifying alternate suppliers, standardizing interfaces, and designing for manufacturability. Third, develop integrated software platforms that support adaptive therapy, remote monitoring, and clinician dashboards; such platforms should be architected to enable third-party integrations and to support scalable data analytics that translate usage into actionable clinical insight.

Fourth, tailor go-to-market strategies by region and end-user segment, aligning pricing, service packages, and training programs to the unique needs of hospitals, rehabilitation centers, and home care markets. Finally, foster partnerships with rehabilitation providers, insurers, and research institutions to accelerate adoption, shorten procurement cycles, and co-create reimbursement pathways that recognize long-term functional benefits. Executing on these recommendations will strengthen commercial defensibility and increase the likelihood of meaningful clinical impact.

A rigorous mixed-methods approach combining primary clinician engagement, observational deployments, literature synthesis, and iterative expert validation to underpin actionable insights

The research methodology combines qualitative and quantitative approaches to ensure robust, reproducible insights. Primary research involved structured interviews with clinicians, procurement specialists, rehabilitation therapists, and device developers to gather firsthand perspectives on usability, clinical requirements, and procurement constraints. These interviews were complemented by observational studies of device deployments in clinical and home settings to assess user flows, setup burdens, and maintenance considerations.

Secondary research synthesized regulatory guidance, published clinical literature, and technical specifications to map technological trajectories and identify common engineering trade-offs. Data triangulation techniques were applied to reconcile differing data sources and to validate thematic findings. Segmentation analysis utilized product form factor, technological architecture, end-user setting, and application laterality to ensure that device categories and use cases were coherently defined and that implications for design and commercialization were clear.

Throughout the research process, iterative expert review panels provided critical validation of assumptions and helped prioritize areas where additional primary data collection or targeted case studies were necessary. Methodological rigor focused on transparency, reproducibility, and relevance to decision-makers seeking actionable insights for product development and go-to-market planning.

A synthesis of how clinical evidence, product engineering, supply chain strategy, and regional go-to-market execution collectively determine successful deployment and patient impact

In summary, the multi-joint upper limb rehabilitation robotics field stands at an inflection point where technological maturity, shifting care delivery models, and policy dynamics converge to create accelerated opportunities and responsibilities for industry stakeholders. Devices are becoming more capable, adaptable, and suited to diverse care settings, yet commercialization success depends on a clear alignment between clinical evidence, service models, and regional market requirements. Supply chain and tariff pressures through 2025 have highlighted the need for manufacturing flexibility and regional strategies that preserve margins while improving time-to-market and service responsiveness.

Going forward, organizations that integrate rigorous clinical validation with modular engineering, resilient sourcing strategies, and software-enabled remote care will be best positioned to deliver sustained value to patients, providers, and payers. Collaborative partnerships with clinical sites and payers will accelerate adoption, while tailored regional approaches will unlock growth in areas with distinct reimbursement and procurement dynamics. The pathway to impact requires disciplined execution across evidence generation, product design, and commercialization, with a constant focus on measurable functional outcomes and total cost of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Multi-joint Upper Limb Rehabilitation Robot Market, by Product

  • 8.1. Stationary
  • 8.2. Wearable

9. Multi-joint Upper Limb Rehabilitation Robot Market, by Technology

  • 9.1. End Effector
  • 9.2. Exoskeleton

10. Multi-joint Upper Limb Rehabilitation Robot Market, by End User

  • 10.1. Home Care
  • 10.2. Hospitals
  • 10.3. Rehabilitation Centers

11. Multi-joint Upper Limb Rehabilitation Robot Market, by Application

  • 11.1. Bilateral
  • 11.2. Unilateral
    • 11.2.1. Left
    • 11.2.2. Right

12. Multi-joint Upper Limb Rehabilitation Robot Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Multi-joint Upper Limb Rehabilitation Robot Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Multi-joint Upper Limb Rehabilitation Robot Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Multi-joint Upper Limb Rehabilitation Robot Market

16. China Multi-joint Upper Limb Rehabilitation Robot Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Bionik Laboratories Corp.
  • 17.6. Cyberdyne, Inc.
  • 17.7. Ekso Bionics Holdings, Inc.
  • 17.8. Focal Meditech BV
  • 17.9. Fourier Intelligence Co., Ltd.
  • 17.10. Hocoma AG
  • 17.11. Honda Motor Co., Ltd.
  • 17.12. Kinova Inc.
  • 17.13. Marsi Bionics
  • 17.14. Myomo, Inc.
  • 17.15. Neofect Co., Ltd.
  • 17.16. Ottobock SE & Co. KGaA
  • 17.17. Parker-Hannifin Corporation
  • 17.18. Reha Technology AG
  • 17.19. ReWalk Robotics Ltd.
  • 17.20. Steeper Group Ltd.
  • 17.21. Tyromotion GmbH
  • 17.22. UBTECH Robotics Corp.
  • 17.23. Wandercraft SAS
  • 17.24. Yaskawa Electric Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END EFFECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END EFFECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END EFFECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY EXOSKELETON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY EXOSKELETON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY EXOSKELETON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY BILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY BILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY BILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY LEFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY LEFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY LEFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY RIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY RIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY RIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 55. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 96. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 98. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 114. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 116. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 120. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)